Display options
Share it on

Toxicol Rep. 2015 Aug 10;2:1149-1156. doi: 10.1016/j.toxrep.2015.08.001. eCollection 2015.

Green tea extract attenuates CCl4-induced hepatic injury in male hamsters via inhibition of lipid peroxidation and p53-mediated apoptosis.

Toxicology reports

Rania Abdel Rahman Elgawish, Haidy G Abdel Rahman, Heba M A Abdelrazek

Affiliations

  1. Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
  2. Department of Clinical Pathology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
  3. Department of Physiology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.

PMID: 28962456 PMCID: PMC5598372 DOI: 10.1016/j.toxrep.2015.08.001

Abstract

Keeping in mind the beneficial effects of GTE administration on liver damage, the present study was undertaken to evaluate the hepatoprotective effect of green tea extract (GTE) against carbon tetrachloride (CCl4)-induced liver injuries in male hamsters for 8 weeks. Twenty hamsters were equally divided into 4 groups, the control ones (group I) received only dis. water. Hamsters of group II had free access to 10% of GTE, while hamsters of group III received 1 ml/kg of 50% CCl4 in corn oil via gavage daily. Hamsters of group IV (GTE + CCl4) received a free access to GTE supplementation in combination with 1 ml/kg of 50% CCl4 in corn oil via gavage daily. Lipid profile, hepatic enzyme levels and apoptosis molecular marker (p53) were investigated in hamsters. GTE + CCl4 treated hamsters showed lower levels of hepatic malondialdehyde (MDA) than CCl4 exposed hamsters. Hepatic activity levels of GSH, ALD and cytochrome 450 reductase were declined after CCl4 administration while they were remarkably improved with GTE administration. Serum lipid profiles as T-cholesterol (TC), triglyceride (TG) and low density lipoproteins (LDL) were improved in GTE and CCl4 treated hamsters than CCl4 group. Moreover, hepatic tissue damage and p53 expression induced with CCl4 were improved with the treatment of GTE. These results suggested that GTE possesses hepatoprotective properties against the effect of CCl4.

Keywords: CCl4; Green tea; Hepatotoxicity; Lipid profile; p53

References

  1. Nat Rev Mol Cell Biol. 2004 Nov;5(11):897-907 - PubMed
  2. Am J Physiol Renal Physiol. 2005 May;288(5):F1005-14 - PubMed
  3. Biochem Biophys Res Commun. 2010 Mar 12;393(3):536-41 - PubMed
  4. J Ethnopharmacol. 2005 Feb 28;97(2):273-80 - PubMed
  5. Cell Biochem Funct. 1999 Dec;17 (4):253-9 - PubMed
  6. World J Gastroenterol. 2013 Jun 28;19(24):3781-91 - PubMed
  7. J Nutr. 2003 Oct;133(10):3275S-84S - PubMed
  8. Liver Int. 2008 Aug;28(7):990-6 - PubMed
  9. Chem Phys Lipids. 2002 Dec;120(1-2):109-17 - PubMed
  10. Blood. 2010 Jan 14;115(2):306-14 - PubMed
  11. Mol Cell. 2002 Mar;9(3):459-70 - PubMed
  12. Biosci Biotechnol Biochem. 2012;76(12 ):2294-300 - PubMed
  13. Oxid Med Cell Longev. 2014;2014:893212 - PubMed
  14. J Nutr Biochem. 2007 Dec;18(12):795-805 - PubMed
  15. Alcohol Res Health. 2007;30(1):5-13 - PubMed
  16. Chem Biol Interact. 2009 Dec 10;182(2-3):159-64 - PubMed
  17. Ann Hepatol. 2008 Oct-Dec;7(4):331-8 - PubMed
  18. Am J Chin Med. 2010;38(1):99-111 - PubMed
  19. Hepatology. 2004 Jul;40(1):185-94 - PubMed
  20. Yonsei Med J. 2004 Aug 31;45(4):703-10 - PubMed
  21. Arch Histol Cytol. 2008 Nov;71(3):163-78 - PubMed
  22. Food Chem Toxicol. 2008 Dec;46(12 ):3714-20 - PubMed
  23. Clin Liver Dis. 2007 Feb;11(1):17-23, vii - PubMed
  24. BMC Complement Altern Med. 2012 Oct 08;12 :178 - PubMed
  25. Curr Pharm Des. 2011;17(1):27-37 - PubMed
  26. Crit Rev Toxicol. 2003;33(2):105-36 - PubMed
  27. Chem Biol Interact. 2006 Aug 25;162(2):157-64 - PubMed
  28. Pak J Pharm Sci. 2010 Jan;23(1):21-8 - PubMed
  29. Carcinogenesis. 2000 Jul;21(7):1441-51 - PubMed
  30. J Formos Med Assoc. 2012 Oct;111(10):550-9 - PubMed
  31. Expert Opin Drug Metab Toxicol. 2014 Dec;10 (12 ):1663-76 - PubMed
  32. Eur J Gastroenterol Hepatol. 2009 Aug;21(8):908-14 - PubMed
  33. Iran J Basic Med Sci. 2014 Oct;17(10):740-6 - PubMed
  34. BMC Complement Altern Med. 2012 Aug 21;12:133 - PubMed
  35. World J Gastroenterol. 2006 Oct 14;12(38):6198-202 - PubMed
  36. Am J Cardiol. 2009 Nov 16;104(10 Suppl):52E-7E - PubMed
  37. J Biol Chem. 1995 Feb 3;270(5):2344-51 - PubMed
  38. J Biomed Sci. 2009 Mar 25;16:35 - PubMed
  39. World J Gastroenterol. 2009 Apr 21;15(15):1829-35 - PubMed
  40. Cell. 2000 Jul 7;102(1):33-42 - PubMed
  41. Am J Clin Nutr. 2004 Sep;80(3):742-51 - PubMed
  42. J Pharmacol Exp Ther. 1995 Dec;275(3):1614-22 - PubMed
  43. Anal Biochem. 1979 Jun;95(2):351-8 - PubMed
  44. Food Chem. 2013 Feb 15;136(3-4):1337-44 - PubMed
  45. Mol Aspects Med. 2000 Jun;21(3):49-98 - PubMed
  46. Anal Biochem. 1969 Mar;27(3):502-22 - PubMed
  47. Toxicol Appl Pharmacol. 1984 Aug;75(1):1-7 - PubMed
  48. J Gastroenterol Hepatol. 2003 Jul;18(7):851-7 - PubMed
  49. Food Chem Toxicol. 2006 Jul;44(7):1108-13 - PubMed
  50. World J Gastroenterol. 2013 Aug 21;19(31):5174-7 - PubMed
  51. Lab Invest. 2010 Dec;90(12):1805-16 - PubMed
  52. Free Radic Biol Med. 2003 Jan 1;34(1):1-10 - PubMed

Publication Types